Literature DB >> 1211925

Relation between lipophilicity and pharmacological behavior of minocycline, doxycycline, tetracycline, and oxytetracycline in dogs.

M Barza, R B Brown, C Shanks, C Gamble, L Weinstein.   

Abstract

Four tetracyclines were studied in dogs to determine the relation between their lipophilicity and various other pharmacological characteristics. Lipid solubility correlated inversely with the mean concentration of drug in arterial plasma and renal uptake and excretion, and directly with the biliary concentration gradient (level in bile/level of free drug in serum). Only the more lipophilic congeners minocycline and doxycycline passed the blood-brain and blood-ocular barriers in detectable concentrations. Mean levels of minocycline in the brain exceeded those of doxycycline by almost threefold; the difference was of borderline statistical significance (P = 0.05 to 0.1). Lipophilicity correlated inversely with the concentration of antibiotic in renal medulla but not in renal cortex or in the liver. When intestinal loops containing saline, milk, or 10% Gelusil were studied, the only combination exhibiting striking intraluminal accumulation was doxycycline in milk. These results indicate that lipophilicity correlates with many, but not all, of the transport characteristics of tetracycline antibiotics.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1211925      PMCID: PMC429453          DOI: 10.1128/AAC.8.6.713

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  33 in total

1.  Avidity of the tetracyclines for the cations of metals.

Authors:  A ALBERT; C W REES
Journal:  Nature       Date:  1956-03-03       Impact factor: 49.962

2.  Avidity of terramycin and aureomycin for metallic cations.

Authors:  A ALBERT
Journal:  Nature       Date:  1953-08-01       Impact factor: 49.962

Review 3.  Pharmacokinetics and molecular modification: implications in drug design and evaluation.

Authors:  R E Notari
Journal:  J Pharm Sci       Date:  1973-06       Impact factor: 3.534

4.  Minocycline excretion and distribution in relation to renal function in man.

Authors:  S Carney; R A Butcher; J K Dawborn; G Pattison
Journal:  Clin Exp Pharmacol Physiol       Date:  1974 Jul-Aug       Impact factor: 2.557

5.  Tissue distribution of tetracycline and chlortetracycline in the dog.

Authors:  R G Kelly; L A Kanegis
Journal:  Toxicol Appl Pharmacol       Date:  1967-07       Impact factor: 4.219

6.  Short-term toxicity and observations on certain aspects of the pharmacology of a unique tetracycline--minocycline.

Authors:  J F Noble; L A Kanegis; D W Hallesy
Journal:  Toxicol Appl Pharmacol       Date:  1967-07       Impact factor: 4.219

7.  Serum and cerebrospinal fluid concentrations of a new tetracycline, doxycycline.

Authors:  G Mento; G Ceccarelli; A Lazzara; G Megna
Journal:  Chemotherapy       Date:  1969       Impact factor: 2.544

8.  [Kinetics of tetracyclines in human. II. Excretion, penetration into normal and inflammed tissues, behavior in a case of renal insufficiency and in hemodialysis].

Authors:  J Fabre; E Milek; P Kalfopoulos; G Mérier
Journal:  Schweiz Med Wochenschr       Date:  1971-05-08

9.  The disposition of doxycycline by the rat.

Authors:  M Schach VON WITTENAU; M Schachaavonwittenau; T M Twomey; A C Swindell
Journal:  Chemotherapy       Date:  1972       Impact factor: 2.544

10.  pH-Partition behavior of tetracyclines.

Authors:  J L Colaizzi; P R Klink
Journal:  J Pharm Sci       Date:  1969-10       Impact factor: 3.534

View more
  46 in total

1.  Minocycline Directly Enhances the Self-Renewal of Adult Neural Precursor Cells.

Authors:  Anri Kuroda; Takahiro Fuchigami; Satoshi Fuke; Natsu Koyama; Kazuhiro Ikenaka; Seiji Hitoshi
Journal:  Neurochem Res       Date:  2017-10-28       Impact factor: 3.996

2.  Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia.

Authors:  J Yrjänheikki; R Keinänen; M Pellikka; T Hökfelt; J Koistinaho
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-22       Impact factor: 11.205

Review 3.  Protein binding of antimicrobials: clinical pharmacokinetic and therapeutic implications.

Authors:  W A Craig; P G Welling
Journal:  Clin Pharmacokinet       Date:  1977 Jul-Aug       Impact factor: 6.447

4.  Doxycycline Used for Control of Transgene Expression has its Own Effects on Behaviors and Bcl-xL in the Rat Hippocampus.

Authors:  G T Shishkina; D A Lanshakov; A V Bannova; T S Kalinina; N P Agarina; N N Dygalo
Journal:  Cell Mol Neurobiol       Date:  2017-08-31       Impact factor: 5.046

5.  Survival of treponemes after treatment: comments, clinical conclusions, and recommendations.

Authors:  E M Dunlop
Journal:  Genitourin Med       Date:  1985-10

6.  Side effects of minocycline: a double-blind study.

Authors:  W L Fanning; D W Gump; R A Sofferman
Journal:  Antimicrob Agents Chemother       Date:  1977-04       Impact factor: 5.191

7.  A novel action of minocycline: inhibition of human immunodeficiency virus type 1 infection in microglia.

Authors:  Qiusheng Si; Melissa Cosenza; Mee-Ohk Kim; Meng-Liang Zhao; Michael Brownlee; Harris Goldstein; Sunhee Lee
Journal:  J Neurovirol       Date:  2004-10       Impact factor: 2.643

8.  Pharmacokinetics of sparfloxacin in the serum and vitreous humor of rabbits: physicochemical properties that regulate penetration of quinolone antimicrobials.

Authors:  W Liu; Q F Liu; R Perkins; G Drusano; A Louie; A Madu; U Mian; M Mayers; M H Miller
Journal:  Antimicrob Agents Chemother       Date:  1998-06       Impact factor: 5.191

Review 9.  Minocycline: far beyond an antibiotic.

Authors:  N Garrido-Mesa; A Zarzuelo; J Gálvez
Journal:  Br J Pharmacol       Date:  2013-05       Impact factor: 8.739

10.  In vitro and in vivo effects of doxycycline on Toxoplasma gondii.

Authors:  H R Chang; R Comte; J C Pechère
Journal:  Antimicrob Agents Chemother       Date:  1990-05       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.